HF-rTMS treatment in medication-resistant melancholic depression: Results from 18FDG-PET brain imaging

CNS Spectrums

Volumn 14, Issue 8, 2009, Pages 439-448

  Baeken, Chris ^a   De Raedt, Rudi ^b   Van Hove, Christian ^a   Clerinx, Peter ^a   De Mey, Johan ^a   Bossuyt, Axel ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BASAL METABOLIC RATE; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIATHERMY; FEMALE; GLUCOSE METABOLISM; HAMILTON SCALE; HUMAN; IMAGE ANALYSIS; MAJOR DEPRESSION; MALE; MELANCHOLIA; METABOLIC ACTIVATION; MOOD CHANGE; NEUROIMAGING; OPEN STUDY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; REPEAT PROCEDURE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 70849083981     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900020411     Document Type: Article

References (71)

1. Schlaepfer TE, Kosel M, Nemeroff CB. Efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of affective disorders. Neuropsychopharmacology. 2003;28:201-205.
2. O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208-1216. (Pubitemid 350060890)
3. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol. 2002;5:73-103. (Pubitemid 34241070)
4. George MS, Nahas Z, Li X, et al. Novel treatments of mood disorders based on brain circuitry (ECT, MST, TMS, VNS, DBS). Semin Clin Neuropsychiatry. 2002;7:293-304.
5. Simons W, Dierick M. Transcranial magnetic stimulation as a therapeutic tool in psychiatry. World J Biol Psychiatry. 2005;6:6-25. (Pubitemid 40724323)
6. Paus T, Barrett J. Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression. J Psychiatry Neurosci. 2004;29:268-279. (Pubitemid 39179573)
7. Fitzgerald PB, Oxley TJ, Laird AR, Kulkarni J, Egan GF, Daskalakis ZJ. An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depression. Psychiatry Res. 2006;148:33-45. (Pubitemid 44679820)
8. Martin JL, Barbanoj MJ, Schlaepfer TE, Thompson E, Perez V, Kulisevsky J. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry. 2003;182:480-491. (Pubitemid 36649193)
9. Gross M, Nakamura L, Pascual-Leone A, Fregni F. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr Scand. 2007;116:165-173.
10. Post A, Keck ME. Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? J Psychiatr Res. 2001;35:193-215.
11. Ben-Shachar D, Gazawi H, Riboyad-Levin J, Klein E. Chronic repetitive transcranial magnetic stimulation alters beta-adrenergic and 5-HT2 receptor characteristics in rat brain. Brain Res. 1999;816:78-83. (Pubitemid 29225425)
12. Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci. 2001;21:RC157.
13. Speer AM, Kimbrell TA, Wasserman ED, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry. 2000;48:1133-1141.
14. Knoch D, Treyer V, Regard M, Müri RM, Buck A, Weber B. Lateralized and frequency-dependent effects of prefrontal rTMS on regional cerebral blood flow. Neuroimage. 2006;31:641-648. (Pubitemid 43776662)
15. Kimbrell TA, Little JT, Dunn RT, et al. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation as a function of baseline cerebral glucose metabolism. Biol Psychiatry. 1999;46:1603-1613.
16. Teneback CC, Nahas Z, Speer AM, et al. Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS. J Neuropsychiatry Clin Neurosci. 1999;11:426-435.
17. Eschweiler GW, Wegerer C, Schlotter W, et al. Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychiatry Res. 2000;99:161-172. (Pubitemid 30799369)
18. Langguth B, Wiegand R, Kharraz A, et al. Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS). Neuro Endocrinol Lett. 2007;28:633-638.
19. Nahas Z, Teneback CC, Kozel A, et al. Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance. J Neuropsychiatry Clin Neurosci. 2001;13:459-470. (Pubitemid 33140919)
20. Paus T, Castro-Alamancos MA, Petrides M. Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation. Eur J Neurosci. 2001;14:1405-1411. (Pubitemid 35463746)
21. Li X, Nahas Z, Kozel FA, Anderson B, Bohning DE, George MS. Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical as well as subcortical regions. Biol Psychiatry. 2004;55:882-890. (Pubitemid 38526300)
22. Luborzewski A, Schubert F, Seifert F, et al. Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression. J Psychiatr Res. 2007;41:606-615. (Pubitemid 46335915)
23. Brakemeier EL, Luborzewski A, Danker-Hopfe H, Kathmann N, Bajbouj MJ. Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). J Psychiatr Res. 2007;41:395-403. (Pubitemid 46188714)
24. Mayberg HS, Brannan SK, Mahurin RK, et al. Cingulate function in depression: A potential predictor of treatment response. Neuroreport. 1997;8:1057-1061.
25. Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull. 2003;65:193-207.
26. Dougherty DD, Rauch SL. Brain correlates of antidepressant treatment outcome from neuroimaging studies in depression. Psychiatr Clin North Am. 2007;30:91-103. (Pubitemid 46386304)
27. Drevets WC. Functional neuro-imaging studies of depression: the anatomy of melancholia. Annu Rev Med. 1998;49:341-361.
28. Leventhal AM, Rehm LP. The empirical status of melancholia: implications for psychology. Clin Psychol Rev. 2005;25:25-44.
29. Thase ME, Rush A. When at first you don't succeed: Sequential strategies for antidepressant nonresponders. J Clin Psychiatry. 1997;58(suppl 13):23-29. (Pubitemid 28011969)
30. Rush AJ, Thase ME, Dubé S. Research issues in the study of difficult-to-treat depression. Biol Psychiatry. 2003;53:743-753. (Pubitemid 39658488)
31. Van Strien JW. Handvoorkeur en taaldominantie. Neuropraxis. 2001;2:10-15.
32. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33. (Pubitemid 29001829)
33. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278-296.
34. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
35. Beck AT, Steer RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol. 1984;40:1365-1367.
36. Peleman K, Van Schuerbeek P, Luypaert R, et al. Using 3D-MRI to localize the Dorsolateral Prefrontal Cortex in TMS Research. World J Biol Psychiatry. (in press).
37. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol. 1998;108:1-16.
38. Keel JC, Smith MJ, Wassermann EM. A safety screening questionnaire for transcranial magnetic stimulation. Clin Neurophysiol. 2001;112:720. (Pubitemid 32245647)
39. Anand S, Hotson J. Transcranial magnetic stimulation: neurophysiological applications and safety. Brain Cogn. 2002;50:366-386. (Pubitemid 36042963)
40. Ashburner J, Friston KJ. Nonlinear Spatial Normalization using Basis Functions. Hum Brain Mapp. 1999;7:254-266. (Pubitemid 29269964)
41. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fmri data sets. Neuroimage. 2003;19:1233-1239.
42. Bush G, Luu P, Posner MI. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci. 2000;4:215-222. (Pubitemid 30332147)
43. Davidson RJ, Lewis DA, Alloy LB, et al. Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry. 2002;52:478-502.
44. Evans KC, Dougherty DD, Pollack MH, Rauch SL. Using neuroimaging to predict treatment response in mood and anxiety disorders. Ann Clin Psychiatry. 2006;18:33-42.
45. Pridmore S, Bruno R, Turnier-Shea Y, Reid P, Rybak M. Comparison of unlimited numbers of rapid transcranial magnetic stimulation and ECT treatment sessions in major depressive episode. Int J Neuropsychopharmacol. 2000;3:129-134. (Pubitemid 30429356)
46. Figiel GS, Epstein C, McDonald WM, et al. The use of rapid-rate transcranial magnetic stimulation in refractory depressed patients. J Neuropsychiatry Clin Neurosci. 1998;10:20-25. (Pubitemid 28135119)
47. Grunhaus L, Dannon PN, Schreiber S, et al. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry. 2000;47:314-324. (Pubitemid 30109244)
48. Holtzheimer PE 3rd, Russo J, Claypoole KH, Roy-Byrne P, Avery DH. Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation. Depress Anxiety. 2004;19:24-30.
49. Loo CK, Mitchell PB. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J Affect Disord. 2005;88:255-267. (Pubitemid 41447523)
50. Kimbrell TA, Ketter TA, George MS, et al. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry. 2002;51:237-252.
51. Conca A. Peschina W, Konig P, Fritzsche H, Hausmann A. Effect of chronic repetitive transcranial magnetic stimulation on regional cerebral blood flow and regional cerebral glucose uptake in drug treatment-resistant depressives. A brief report. Neuropsychobiology. 2002;45:27-31.
52. Brody AL, Saxena S, Silverman DH, et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res. 1999;91:127-139. (Pubitemid 29474048)
53. Brody AL, Saxena S, Mandelkern MA, Fairbanks LA, Ho ML, Baxter LR. Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol Psychiatry. 2001;50:171-178. (Pubitemid 32763094)
54. Mottaghy FM, Keller CE, Gangitano M, et al. Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Res. 2002;115:1-14. (Pubitemid 34880095)
55. Catafau AM, Perez V, Gironell A, et al. SPECT mapping of cerebral activity changes induced by repetitive transcranial magnetic stimulation in depressed patients. A pilot study. Psychiatry Res. 2001;106:151-160.
56. Nadeau SE, McCoy KJ, Crucian GP, et al. Cerebral blood flow changes in depressed patients after treatment with repetitive transcranial magnetic stimulation: evidence of individual variability. Neuropsychiatry Neuropsychol Behav Neurol. 2002;15:159-175. (Pubitemid 35006771)
57. Loo CK, Sachde, PS, Haindl W, et al. High (15 Hz) and low (1 Hz) frequency transcranial magnetic stimulation have different acute effects on regional cerebral blood flow in depressed patients. Psychol Med. 2003;33:997-1006. (Pubitemid 37009818)
58. Holthoff VA, Beuthien-Baumann B, Zündorf G, et al. Changes in brain metabolism associated with remission in unipolar major depression. Acta Psychiatr Scand. 2004;110:184-194. (Pubitemid 39120321)
59. Shajahan PM, Glabus MF, Steele JD, et al. Left dorso-lateral repetitive transcranial magnetic stimulation affects cortical excitability and functional connectivity, but does not impair cognition in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:945-954.
60. Wu J, Buchsbaum MS, Gillin J, et al. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry. 1999;156:1149-1158. (Pubitemid 29374872)
61. Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, Jerabek PA. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry. 2000;48:830-843. (Pubitemid 30813467)
62. Nobler MS, Oquendo MA, Kegeles LS, et al. Decreased regional brain metabolism after ect. Am J Psychiatry. 2001;158:305-308.
63. Takano H, Motohashi N, Uema T, et al. Changes in regional cerebral blood flow during acute electroconvulsive therapy in patients with depression: positron emission tomographic study. Br J Psychiatry. 2007;190:63-68. (Pubitemid 46121503)
64. Schmidt EZ, Reininghaus B, Enzinger C, Ebner C, Hofmann P, Kapfhammer HP. Changes in brain metabolism after ECT-positron emission tomography in the assessment of changes in glucose metabolism subsequent to electroconvulsive therapy - lessons, limitations and future applications. J Affect Disord. 2008;106:203-208. (Pubitemid 350309675)
65. Pizzagalli D, Pascual-Marqui RD, Nitschke JB, et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry. 2001;158:405-415. (Pubitemid 32205197)
66. Kito S, Fujita K, Koga Y. Changes in regional cerebral blood flow after repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in treatment-resistant depression. J Neuropsychiatry Clin Neurosci. 2008;20:74-80. (Pubitemid 351295031)
67. Drevets WC. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res. 2000;126:413-431.
68. Berman RM, Narasimhan M, Sanacora G, et al. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiatry. 2000;47:332-337. (Pubitemid 30109246)
69. Goldapple K, Segal Z, Garson C, et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry. 2004;61:34-41. (Pubitemid 38044639)
70. Gershon AA, Dannon PN, Grunhaus L. Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry. 2003;160:835-845.
71. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct. 2008;213:93-118.